Liver transplantation is the only cure for end-stage liver disease, but donor organ scarcity limits access for millions. Split liver transplantation could help bridge this gap, but the regeneration of partial organs is critical to broadlyimplementing this approach. Vanderbilt University researchers have identified a growth factor that promotes liver growth that could be used to improve patient outcomes and increase accessibility to liver transplantation.
